Oral compositions containing zinc, stannous and fluoride ion sources
US-10154948-B2 · Dec 18, 2018 · US
US11253444B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11253444-B2 |
| Application number | US-201616309402-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 24, 2016 |
| Priority date | Jun 24, 2016 |
| Publication date | Feb 22, 2022 |
| Grant date | Feb 22, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to an oral care composition for use in the treatment or prevention of erosive tooth demineralization, plaque, and caries. This oral care composition includes zinc lactate dihydrate, a stannous ion source, at least one phosphate salt, and a buffer system.
Opening claim text (preview).
What is claimed is: 1. A method of treating or reducing demineralization of teeth in the oral cavity comprising administering an oral care composition to the oral cavity of a subject in need thereof, where the oral care composition, comprises an orally acceptable carrier and: zinc lactate, wherein the composition comprises zinc lactate in an amount of about 2.5% by weight of the composition; a stannous ion source, wherein the stannous ion source is stannous fluoride present in an amount of from 0.1 to 3% by weight of the oral care composition; a phosphate salt, wherein the phosphate salt is selected from tetrasodium pyrophosphate and/or sodium tripolyphosphate, wherein the amount of the phosphate salt is from 1% to 10% by weight of the oral care composition; a citrate buffer system, wherein the citrate buffer system comprises citric acid and trisodium citrate; and about 4% propylene glycol. 2. The method of claim 1 , wherein the zinc lactate is zinc lactate dihydrate. 3. The method of claim 1 , wherein the orally acceptable carrier comprises water from 10 to 40% by weight of the oral care composition. 4. The method of claim 1 , which is a single phase composition. 5. The method according to claim 1 , wherein the oral care composition comprises: a) about 2.5% zinc lactate; b) about 3.6% citrate buffer; c) about 0.45% stannous fluoride; d) about 3% sodium tripolyphosphate (STPP); and e) about 2% tetrasodium pyrophosphate (TSPP). 6. The method of claim 1 , wherein the oral care composition is a toothpaste or dental gel.
Related publications grouped by family.
Answers are generated from the same data shown on this page.